LY2828360
CAS: 1231220-79-3
Ref. 3D-GZB22079
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Información del producto
LY2828360 is a low-potency cannabinoid receptor agonist that has been shown to antagonize the effects of the endogenous cannabinoid anandamide. This compound has been studied in clinical studies for its potential use as an anti-inflammatory and analgesic agent. LY2828360 is also a CB2 receptor agonist, which has been shown to have potential uses in treating inflammatory diseases such as arthritis, inflammatory bowel disease, or pain models. LY2828360 has also shown efficacy in animal models of colorectal adenocarcinoma and other cancers.
Propiedades químicas
Consulta técnica sobre: 3D-GZB22079 LY2828360
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
